Eurofins Scientific
Search results
As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience. WHAT WE DO.
As a mid-sized global biopharmaceutical company, Ipsen improves people’s lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Ipsen focuses on platform products by delivering the first TITAN® vacuum and ATLAS® atmosphere standard furnaces. The PdMetrics software platform launches, which integrates with the IoT and provides predictive maintenance capabilities.
Ipsen | 226,179 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease...
Ipsen | 228,489 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease...
Ipsen India operates out of our state-of-the-art manufacturing plant in Kolkata, as well as regional offices that provide support to our customers throughout the country and surrounding regions. +91 20 2553 5045
Ipsen India exemplifies the power of collaboration in Ipsen’s journey towards growth and excellence. The history of Ipsen India began in 1982 when a licensing agreement was formed between Ipsen International in Germany and a Kolkata based industrial company.
